Exhibit 32(b)

            CERTIFICATION OF CHIEF FINANCIAL OFFICER
               PURSUANT TO 18 U.S.C. SECTION 1350,
                     AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In  connection  with  the  IGENE  Biotechnology,  Inc.  (the
"Company") Quarterly Report on Form 10-QSB/A for the period ended
June  30,  2004,  as  filed  with  the  Securities  and  Exchange
Commission  on  the  date  hereof (the "Report"),  I,  Edward  J.
Weisberger,  Chief  Financial Officer  of  the  Company,  certify
pursuant  to  18  U.S.C.  Section 1350, as  adopted  pursuant  to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to the  best
of my knowledge:

     (1). The  Report  fully  complies  with  the requirements of
          Section 13(a) or 15(d) of  the  Securities Exchange Act
          of 1934, as amended; and

     (2). The  information   contained  in   the  Report   fairly
          presents,  in   all  material  respects,  the financial
          condition and results of operations of the Company.


Date: September 28, 2005           By: /s/EDWARD J. WEISBERGER
                                       __________________________
                                          EDWARD J. WEISBERGER
                                          Chief Financial Officer




A signed original of this written statement required by Section
906 has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission
or its staff upon request.